-36.1%
HOOD vs GSK
+14.9%
-51.0%
-54.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.0% | +5.0% | -3.0% | +1.5% |
| 7D | -4.4% | +4.9% | -9.3% | -4.9% |
| 30D | -23.4% | +9.9% | -33.3% | -24.2% |
| 3M | -6.5% | +0.2% | -6.7% | -6.1% |
| 6M | +14.2% | +2.3% | +11.9% | +14.0% |
| YTD | -22.7% | +7.1% | -29.8% | -21.1% |
| 1Y | -36.1% | +13.1% | -49.2% | -35.6% |
| All | -36.1% | +14.9% | -51.0% | -35.6% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling